Search Results - "Bergmark, A"

Real-World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation? by Bergmark, Brian A

Get full text

Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy by Bravo, Paco E, Bergmark, Brian A, Vita, Tomas, Taqueti, Viviany R, Gupta, Ankur, Seidelmann, Sara, Christensen, Thomas E, Osborne, Michael T, Shah, Nishant R, Ghosh, Nina, Hainer, Jon, Bibbo, Courtney F, Harrington, Meagan, Costantino, Fred, Mehra, Mandeep R, Dorbala, Sharmila, Blankstein, Ron, Desai, Akshay, Stevenson, Lynne, Givertz, Michael M, Di Carli, Marcelo F

“…Abstract Aims Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart transplant (OHT) survivors. Effective non-invasive screening…”
Get full text

Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization by Oyama, Kazuma, Furtado, Remo H.M., Fagundes, Antonio, Zelniker, Thomas A., Tang, Minao, Kuder, Julia, Murphy, Sabina A., Hamer, Andrew, Wang, Huei, Keech, Anthony C., Giugliano, Robert P., Sabatine, Marc S., Bergmark, Brian A.

“…This study sought to evaluate the ability of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to reduce the risk of complex…”
Get full text

Klotho, fibroblast growth factor‐23, and the renin–angiotensin system — an analysis from the PEACE trial by Bergmark, Brian A., Udell, Jacob A., Morrow, David A., Jarolim, Petr, Kuder, Julia F., Solomon, Scott D., Pfeffer, Marc A., Braunwald, Eugene, Sabatine, Marc S.

“…Aims Klotho, an essential co‐receptor for fibroblast growth factor (FGF)‐23, has potentially beneficial inhibitory effects on the renin–angiotensin system…”
Get full text

Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High-Risk Coronary Anatomical Features by Bergmark, Brian A, Morrow, David A

Get full text

OCT utilization: Summary statistics from the LightLab clinical initiative by Raja, Aishwarya, Osborn, Eric A., Bergmark, Brian A., Croce, Kevin D., Poulin, Marie‐France, Tamez, Hector, West, Nick, Buccola, Jana, Meinen, Jennifer, Secemsky, Eric A.

“…Objectives The study describes the evolution of optical coherence tomography (OCT) adoption and performance during percutaneous coronary intervention (PCI)…”
Get full text

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial by Bergmark, Brian A, O'Donoghue, Michelle L, Murphy, Sabina A, Kuder, Julia F, Ezhov, Marat V, Ceška, Richard, Gouni-Berthold, Ioanna, Jensen, Henrik K, Tokgozoglu, S Lale, Mach, François, Huber, Kurt, Gaciong, Zbigniew, Lewis, Basil S, Schiele, Francois, Jukema, J Wouter, Pedersen, Terje R, Giugliano, Robert P, Sabatine, Marc S

“…Despite recent advances in treatment of severe aortic valve stenosis (AS), AS remains a life-threatening condition with no proven disease-modifying therapy…”
Get more information

Emergent Coronary Thrombectomy for Acute Myocardial Infarction Immediately Following Craniotomy with Tumor Resection by Ginder, Curtis R., Suero-Abreu, Giselle A., Ghumman, Saad S., Bergmark, Brian A., Arnaout, Omar, Giugliano, Robert P.

“…The management of perioperative acute myocardial infarction (AMI) following oncologic neurosurgery requires balancing competing risks of myocardial ischemia…”
Get full text

Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial by Bergmark, Brian A, Bhatt, Deepak L, Steg, P Gabriel, Budaj, Andrzej, Storey, Robert F, Gurmu, Yared, Kuder, Julia F, Im, KyungAh, Magnani, Giulia, Oude Ophuis, Ton, Hamm, Christian, Špinar, Jindřich, Kiss, Robert G, Van de Werf, Frans J, Montalescot, Gilles, Johanson, Per, Braunwald, Eugene, Sabatine, Marc S, Bonaca, Marc P

“…Background Coronary stent type and risk of stent thrombosis remain important factors affecting recommended duration of dual antiplatelet therapy. We…”
Get full text

Acute coronary syndromes by Bergmark, Brian A, Mathenge, Njambi, Merlini, Piera A, Lawrence-Wright, Marilyn B, Giugliano, Robert P

“…Although substantial progress has been made in the diagnosis and treatment of acute coronary syndromes, cardiovascular disease remains the leading cause of…”
Get full text

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis by Sabatine, Marc S, Bergmark, Brian A, Murphy, Sabina A, O'Gara, Patrick T, Smith, Peter K, Serruys, Patrick W, Kappetein, A Pieter, Park, Seung-Jung, Park, Duk-Woo, Christiansen, Evald H, Holm, Niels R, Nielsen, Per H, Stone, Gregg W, Sabik, Joseph F, Braunwald, Eugene

“…The optimal revascularisation strategy for patients with left main coronary artery disease is uncertain. We therefore aimed to evaluate long-term outcomes for…”
Get full text

Cardiac troponin elevation after elective PCI: adding infarct to major injury by Bergmark, Brian A, Morrow, David A

Get full text

Catheter-directed interventions for pulmonary embolism by Kochar, Ajar, Bergmark, Brian A

“…Pulmonary embolism (PE) is common, life-threatening, and often recurrent among survivors. The clinical manifestations of PE range from incidental detection to…”
Get full text

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial by Bergmark, Brian A., Bhatt, Deepak L., McGuire, Darren K., Cahn, Avivit, Mosenzon, Ofri, Steg, Ph. Gabriel, Im, KyungAh, Kanevsky, Estella, Gurmu, Yared, Raz, Itamar, Braunwald, Eugene, Scirica, Benjamin M.

“…BACKGROUNDMetformin is first-line therapy for type 2 diabetes mellitus, although its effects on the cardiovascular system are unproved. METHODSIn this post hoc…”
Get full text

Stuck with Welfare? Long-term Social Assistance Recipiency in Sweden by Bergmark, A.

“…One of the most salient features of the economic crisis in Sweden during the 1990s was the dramatic increase in long-term social assistance recipiency. When…”
Get full text

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk by Bergmark, Brian A, Scirica, Benjamin M, Steg, Ph Gabriel, Fanola, Christina L, Gurmu, Yared, Mosenzon, Ofri, Cahn, Avivit, Raz, Itamar, Bhatt, Deepak L

“…Abstract Aims Optimal blood pressure for prevention of cardiovascular (CV) events in patients with Type 2 diabetes mellitus (T2DM) remains uncertain and there…”
Get full text

Crack initiation and propagation in Chromium pre-alloyed PM-steel under cyclic loading by Gerosa, R., Rivolta, B., Tavasci, A., Silva, G., Bergmark, A.

“…Powder metallurgy processing of steels typically results in materials characterized by residual porosity, whose sizes and morphology, together with the…”
Get full text

Residence and quality of life determinants for adults with tetraplegia of traumatic spinal cord injury etiology by Bergmark, B A, Winograd, C H, Koopman, C

“…Study design:  Cross-sectional analysis of individual interviews with a convenience sample of persons living with tetraplegia. Objectives:  To describe…”
Get full text

Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial by Oyama, Kazuma, Giugliano, Robert P, Tang, Minao, Bonaca, Marc P, Saver, Jeffrey L, Murphy, Sabina A, Ruzza, Andrea, Keech, Anthony C, Sever, Peter S, Sabatine, Marc S, Bergmark, Brian A

“…We assessed the impact of the proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor evolocumab on acute arterial events across all vascular…”
Get full text

Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome? by Bergmark, Brian A, Faxon, David P

“…Abstract…”
Get full text